{"title":"Melittin inhibits MPP<sup>+</sup>-induced HT22 cell death by suppressing Bax activation and improving mitochondrial function.","authors":"Tingting Yu, Zirui Yuan, Jiaona Yu, Lu Chen, Wei Hao, Xiaohui Xu","doi":"10.4196/kjpp.24.293","DOIUrl":null,"url":null,"abstract":"<p><p>Melittin (MEL) is the main bioactive component of bee venom and has been reported to have various pharmacological effects. This study investigates the protective effect of MEL on MPP<sup>+</sup>-injured HT22 cells and the possible mechanisms involved. We treated the cells with 4 mM MPP<sup>+</sup> for 24 h to induce a cellular injury model. HT22 cells were pretreated with 0.1 μM MEL for 6 h and then exposed to 4 mM MPP<sup>+</sup> for 24 h. We measured cell viability, the expression of Bax, the indicators and protein levels associated with apoptosis and parthanatos, and the co-localisation of MEL and mitochondria, and mitochondrial function-related indices such as the mitochondrial membrane potential (MMP) and mito-SOX. We show that PAR protein expression was significantly increased in the MPP<sup>+</sup>-treated cell model and that the parthanatos inhibitor DPQ significantly reduced MPP<sup>+</sup>-induced cell death, suggesting that MPP<sup>+</sup> can cause PARP1-dependent cell death. MEL significantly inhibited cell death, increased cell viability as well as NAD+ and ATP levels, increased the expression of Bcl-2 and suppressed the activation of Bax, cleaved-caspase3, and cleaved- PARP1. Moreover, MEL was found to be localised on the mitochondria of HT22 cells and to improve mitochondrial functions including increased MMP and decreased mitochondrial reactive oxygen species. We speculate that MEL may protect neurons against MPP<sup>+</sup>-induced HT22 cell injury by inhibiting Bax activation, suppressing changes in mitochondrial permeability, and improving mitochondrial function, thereby preventing cell parthanatos and apoptosis.</p>","PeriodicalId":54746,"journal":{"name":"Korean Journal of Physiology & Pharmacology","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Physiology & Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4196/kjpp.24.293","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Melittin (MEL) is the main bioactive component of bee venom and has been reported to have various pharmacological effects. This study investigates the protective effect of MEL on MPP+-injured HT22 cells and the possible mechanisms involved. We treated the cells with 4 mM MPP+ for 24 h to induce a cellular injury model. HT22 cells were pretreated with 0.1 μM MEL for 6 h and then exposed to 4 mM MPP+ for 24 h. We measured cell viability, the expression of Bax, the indicators and protein levels associated with apoptosis and parthanatos, and the co-localisation of MEL and mitochondria, and mitochondrial function-related indices such as the mitochondrial membrane potential (MMP) and mito-SOX. We show that PAR protein expression was significantly increased in the MPP+-treated cell model and that the parthanatos inhibitor DPQ significantly reduced MPP+-induced cell death, suggesting that MPP+ can cause PARP1-dependent cell death. MEL significantly inhibited cell death, increased cell viability as well as NAD+ and ATP levels, increased the expression of Bcl-2 and suppressed the activation of Bax, cleaved-caspase3, and cleaved- PARP1. Moreover, MEL was found to be localised on the mitochondria of HT22 cells and to improve mitochondrial functions including increased MMP and decreased mitochondrial reactive oxygen species. We speculate that MEL may protect neurons against MPP+-induced HT22 cell injury by inhibiting Bax activation, suppressing changes in mitochondrial permeability, and improving mitochondrial function, thereby preventing cell parthanatos and apoptosis.
蜂毒素(MEL)是蜂毒的主要生物活性成分,据报道具有多种药理作用。本研究探讨MEL对MPP+损伤HT22细胞的保护作用及其可能机制。用4 mM MPP+处理24h,建立细胞损伤模型。将HT22细胞用0.1 μM MEL预处理6 h,然后用4 mM MPP+处理24 h。我们测量了细胞活力、Bax表达、凋亡和旁thanatos相关指标和蛋白水平、MEL和线粒体共定位以及线粒体膜电位(MMP)和mito-SOX等线粒体功能相关指标。我们发现,在MPP+处理的细胞模型中,PAR蛋白表达显著增加,parthanatos抑制剂DPQ显著减少MPP+诱导的细胞死亡,表明MPP+可以引起parp1依赖性细胞死亡。MEL显著抑制细胞死亡,提高细胞活力以及NAD+和ATP水平,增加Bcl-2的表达,抑制Bax、cleaved-caspase3和cleaved- PARP1的激活。此外,MEL被发现定位于HT22细胞的线粒体上,并改善线粒体功能,包括增加MMP和减少线粒体活性氧。我们推测MEL可能通过抑制Bax激活、抑制线粒体通透性变化、改善线粒体功能,从而防止细胞旁thanatos和凋亡,从而保护神经元免受MPP+诱导的HT22细胞损伤。
期刊介绍:
The Korean Journal of Physiology & Pharmacology (Korean J. Physiol. Pharmacol., KJPP) is the official journal of both the Korean Physiological Society (KPS) and the Korean Society of Pharmacology (KSP). The journal launched in 1997 and is published bi-monthly in English. KJPP publishes original, peer-reviewed, scientific research-based articles that report successful advances in physiology and pharmacology. KJPP welcomes the submission of all original research articles in the field of physiology and pharmacology, especially the new and innovative findings. The scope of researches includes the action mechanism, pharmacological effect, utilization, and interaction of chemicals with biological system as well as the development of new drug targets. Theoretical articles that use computational models for further understanding of the physiological or pharmacological processes are also welcomed. Investigative translational research articles on human disease with an emphasis on physiology or pharmacology are also invited. KJPP does not publish work on the actions of crude biological extracts of either unknown chemical composition (e.g. unpurified and unvalidated) or unknown concentration. Reviews are normally commissioned, but consideration will be given to unsolicited contributions. All papers accepted for publication in KJPP will appear simultaneously in the printed Journal and online.